+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Next Generation Cancer Diagnostics Market Size, Share & Trends Analysis Report By Technology (LOAC & RT-PCR, Protein Microarrays), By Application, By Cancer Type, By Function, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 236 Pages
  • August 2023
  • Region: Global
  • Grand View Research
  • ID: 5876160
Description Jump to:
The global next generation cancer diagnostics market size is expected to reach a value of USD 29.31 billion by 2030, growing at a CAGR of 9.3% from 2023 to 2030. The growth of the market is attributed to the increased demand for diagnostics due to the rising incidence of oncology conditions aided by the rising development and introduction of novel product offerings. Next-generation technology offers high-value opportunities and growth prospects, specifically with the accelerated development of companion diagnostics for personalized and advanced genomic medicine.

The integration of epigenetic analysis into next-generation diagnostics has the potential to unlock novel biomarkers and therapeutic targets. By deciphering the epigenetic alterations specific to different types or subtypes, researchers and clinicians gain the ability to identify new pathways for personalized treatment approaches. This has helped in providing new opportunities for developing innovative diagnostic tools, therapeutic interventions, and precision medicine strategies. For instance, in April 2023, the new double multi-omics solution by biomodal was launched commercially, showcasing the combined potential of genetic and epigenetic information obtained from a single low-volume sample. This innovative solution provides diverse data modalities that can be leveraged for various applications, beginning with 10ng of cell-free DNA input.

The active participation of global organizations such as the National Cancer Institute, Cancer Research Institute, National Foundation for Cancer Research, and Cancer Research UK supports the growth of the global market. In addition, advancements in diagnostic laboratories and the adoption of integrated and automated lab systems provide extensive opportunities for advanced workflow systems, leading to increased revenue generation over the forecast period. Moreover, the transition from traditional laboratory testing to rapid point-of-care testing, facilitated by the anticipated commercialization of technologically advanced products, including diagnostic kits, instruments, and reagents, is further fueling the growth of the market.

In February 2023, the WHO released a Global Breast Cancer Initiative Framework, outlining a roadmap to save 2.5 million lives from cancer by 2040. The launch of the new framework combines and coincides with the upcoming World Cancer Day campaign and recommends that countries implement the three pillars of health promotion for timely diagnosis, early detection, and suitable management to attain the targets set forth.

Next Generation Cancer Diagnostics Market Report Highlights

  • Based on technology, the next-generation sequencing segment dominated the market in 2022 with a revenue share of 36.6% owing to continuous advancements in NGS technology, growing interest in genomic research, and expanding clinical applications of NGS
  • In terms of application, the biomarker development segment dominated the market in 2022 with a revenue share of 40.68% due to the rising prevalence of cancer. In addition, high accuracy levels are demonstrated by biomarker tests, reaching up to 90% in investigational studies, and their ability to enhance sensitivity in tumor screening
  • Based on cancer type, the others segment dominated the market in 2022 with a revenue share of 44.28%. The dominance of the segment is due to the rising advancements in next-generation technologies that have enabled more accurate and comprehensive detection and profiling of various types of biomarkers
  • In 2022, North America dominated the market for next-generation in 2022 with a revenue share of 40.52%, owing to the larger patient pool in the region compared to other regions, aided by a strong focus on research and development and the presence of major players
  • Key players are constantly focusing on product launches and geographical expansion to maintain their presence

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Technology Segment
1.1.1.2. Application Segment
1.1.1.3. Cancer Type Segment
1.1.1.4. Function Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.4.1. Objective - 1
1.4.2. Objective - 2
1.4.3. Objective - 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
Chapter 2. Next-generation Cancer Diagnostics Market: Executive Summary
2.1. Market Snapshot
2.2. Technology and Application Snapshot
2.3. Cancer Type and Function Snapshot
2.4. Competitive Landscape Snapshot
Chapter 3. Next-generation Cancer Diagnostics Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.4. Market Drivers Analysis
3.4.1. Exponentially decreasing cost of genetic sequencing
3.4.2. Development of cluster chip technology and potential applications of CTC in cancer management
3.4.3. Rising demand for preventive medicine & companion diagnostics
3.4.4. Growing cancer incidence
3.5. Market Restraint Analysis
3.5.1. Requirement of expensive laboratory set-up for implementation of novel tests
3.6. Porter’s Five Forces Analysis
3.7. PESTLE Analysis
3.8. Pipeline Analysis
Chapter 4. Next-generation Cancer Diagnostics Market: Technology Estimates & Trend Analysis
4.1. Next-generation Cancer Diagnostics Market: Technology Movement Analysis
4.2. Next-generation Sequencing
4.2.1. Next-generation Sequencing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.3. qPCR & Multiplexing
4.3.1. qPCR & Multiplexing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.4. LOAC & RT-PCR
4.4.1. LOAC & RT-PCR Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.5. Protein Microarrays
4.5.1. Protein Microarrays Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.6. DNA Microarrays
4.6.1. DNA Microarrays Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Next-generation Cancer Diagnostics Market: Application Estimates & Trend Analysis
5.1. Next-generation Cancer Diagnostics Market: Application Movement Analysis
5.2. Biomarker Development
5.2.1. Biomarker Development Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3. CTC Analysis
5.3.1. CTC Analysis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Proteomic Analysis
5.4.1. Proteomic Analysis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Epigenetic Analysis
5.5.1. Epigenetic Analysis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Genetic Analysis
5.6.1. Genetic Analysis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Next-generation Cancer Diagnostics Market: Cancer Type Estimates & Trend Analysis
6.1. Next-generation Cancer Diagnostics Market: Cancer Type Movement Analysis
6.2. Lung Cancer
6.2.1. Lung Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3. Breast Cancer
6.3.1. Breast Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Colorectal Cancer
6.4.1. Colorectal Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Cervical Cancer
6.5.1. Cervical Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Others
6.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Next-generation Cancer Diagnostics Market: Function Estimates & Trend Analysis
7.1. Next-generation Cancer Diagnostics Market: Cancer Type Movement Analysis
7.2. Therapeutic Monitoring
7.2.1. Therapeutic Monitoring Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Companion Diagnostics
7.3.1. Companion Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Prognostics
7.4.1. Prognostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Cancer Screening
7.5.1. Cancer Screening Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Risk Analysis
7.6.1. Risk Analysis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Next-generation Cancer Diagnostics Market: Regional Business Analysis
8.1. Regional Market Snapshot
8.2. North America
8.2.1. North America Next-generation Cancer Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.2.2. U.S.
8.2.2.1. U.S. Next-generation Cancer Diagnostics Market, 2018 - 2030 (USD Million)
8.2.2.2. Key Country Dynamics
8.2.2.3. Regulatory Framework
8.2.2.4. Reimbursement Scenario
8.2.2.5. Competitive Scenario
8.2.3. CANADA
8.2.3.1. Canada Next-generation Cancer Diagnostics Market, 2018 - 2030 (USD Million)
8.2.3.2. Key Country Dynamics
8.2.3.3. Regulatory Framework
8.2.3.4. Reimbursement Scenario
8.2.3.5. Competitive Scenario
8.3. Europe
8.3.1. Europe Next-generation Cancer Diagnostics Market, 2018 - 2030 (USD Million)
8.3.2. UK
8.3.2.1. UK Next-generation Cancer Diagnostics Market, 2018 - 2030 (USD Million)
8.3.2.2. Key Country Dynamics
8.3.2.3. Regulatory Framework
8.3.2.4. Reimbursement Scenario
8.3.2.5. Competitive Scenario
8.3.3. GERMANY
8.3.3.1. Germany Next-generation Cancer Diagnostics Market, 2018 - 2030 (USD Million)
8.3.3.2. Key Country Dynamics
8.3.3.3. Regulatory Framework
8.3.3.4. Reimbursement Scenario
8.3.3.5. Competitive Scenario
8.3.4. SPAIN
8.3.4.1. Spain Next-generation Cancer Diagnostics Market, 2018 - 2030 (USD Million)
8.3.4.2. Key Country Dynamics
8.3.4.3. Regulatory Framework
8.3.4.4. Reimbursement Scenario
8.3.4.5. Competitive Scenario
8.3.5. FRANCE
8.3.5.1. France Next-generation Cancer Diagnostics Market, 2018 - 2030 (USD Million)
8.3.5.2. Key Country Dynamics
8.3.5.3. Regulatory Framework
8.3.5.4. Reimbursement Scenario
8.3.5.5. Competitive Scenario
8.3.6. ITALY
8.3.6.1. Italy Next-generation Cancer Diagnostics Market, 2018 - 2030 (USD Million)
8.3.6.2. Key Country Dynamics
8.3.6.3. Regulatory Framework
8.3.6.4. Reimbursement Scenario
8.3.6.5. Competitive Scenario
8.3.7. DENMARK
8.3.7.1. Denmark Next-generation Cancer Diagnostics Market, 2018 - 2030 (USD Million)
8.3.7.2. Key Country Dynamics
8.3.7.3. Regulatory Framework
8.3.7.4. Reimbursement Scenario
8.3.7.5. Competitive Scenario
8.3.8. SWEDEN
8.3.8.1. Sweden Next-generation Cancer Diagnostics Market, 2018 - 2030 (USD Million)
8.3.8.2. Key Country Dynamics
8.3.8.3. Regulatory Framework
8.3.8.4. Reimbursement Scenario
8.3.8.5. Competitive Scenario
8.3.9. NORWAY
8.3.9.1. Norway Next-generation Cancer Diagnostics Market, 2018 - 2030 (USD Million)
8.3.9.2. Key Country Dynamics
8.3.9.3. Regulatory Framework
8.3.9.4. Reimbursement Scenario
8.3.9.5. Competitive Scenario
8.4. Asia Pacific
8.4.1. Asia-Pacific Next-generation Cancer Diagnostics Market, 2018 - 2030 (USD Million)
8.4.2. JAPAN
8.4.2.1. Japan Next-generation Cancer Diagnostics Market, 2018 - 2030 (USD Million)
8.4.2.2. Key Country Dynamics
8.4.2.3. Regulatory Framework
8.4.2.4. Reimbursement Scenario
8.4.2.5. Competitive Scenario
8.4.3. CHINA
8.4.3.1. China Next-generation Cancer Diagnostics Market, 2018 - 2030 (USD Million)
8.4.3.2. Key Country Dynamics
8.4.3.3. Regulatory Framework
8.4.3.4. Reimbursement Scenario
8.4.3.5. Competitive Scenario
8.4.4. INDIA
8.4.4.1. India Next-generation Cancer Diagnostics Market, 2018 - 2030 (USD Million)
8.4.4.2. Key Country Dynamics
8.4.4.3. Regulatory Framework
8.4.4.4. Reimbursement Scenario
8.4.4.5. Competitive Scenario
8.4.5. SOUTH KOREA
8.4.5.1. South Korea Next-generation Cancer Diagnostics Market, 2018 - 2030 (USD Million)
8.4.5.2. Key Country Dynamics
8.4.5.3. Regulatory Framework
8.4.5.4. Reimbursement Scenario
8.4.5.5. Competitive Scenario
8.4.6. THAILAND
8.4.6.1. Thailand Next-generation Cancer Diagnostics Market, 2018 - 2030 (USD Million)
8.4.6.2. Key Country Dynamics
8.4.6.3. Regulatory Framework
8.4.6.4. Reimbursement Scenario
8.4.6.5. Competitive Scenario
8.4.7. AUSTRALIA
8.4.7.1. Australia Next-generation Cancer Diagnostics Market, 2018 - 2030 (USD Million)
8.4.7.2. Key Country Dynamics
8.4.7.3. Regulatory Framework
8.4.7.4. Reimbursement Scenario
8.4.7.5. Competitive Scenario
8.5. Latin America
8.5.1. Latin America Next-generation Cancer Diagnostics Market, 2018 - 2030 (USD Million)
8.5.2. BRAZIL
8.5.2.1. Brazil Next-generation Cancer Diagnostics Market, 2018 - 2030 (USD Million)
8.5.2.2. Key Country Dynamics
8.5.2.3. Regulatory Framework
8.5.2.4. Reimbursement Scenario
8.5.2.5. Competitive Scenario
8.5.3. MEXICO
8.5.3.1. Mexico Next-generation Cancer Diagnostics Market, 2018 - 2030 (USD Million)
8.5.3.2. Key Country Dynamics
8.5.3.3. Regulatory Framework
8.5.3.4. Reimbursement Scenario
8.5.3.5. Competitive Scenario
8.5.4. ARGENTINA
8.5.4.1. Argentina Next-generation Cancer Diagnostics Market, 2018 - 2030 (USD Million)
8.5.4.2. Key Country Dynamics
8.5.4.3. Regulatory Framework
8.5.4.4. Reimbursement Scenario
8.5.4.5. Competitive Scenario
8.6. MEA
8.6.1. MEA Next-generation Cancer Diagnostics Market, 2018 - 2030 (USD Million)
8.6.2. SOUTH AFRICA
8.6.2.1. South Africa Next-generation Cancer Diagnostics Market, 2018 - 2030 (USD Million)
8.6.2.2. Key Country Dynamics
8.6.2.3. Regulatory Framework
8.6.2.4. Reimbursement Scenario
8.6.2.5. Competitive Scenario
8.6.3. SAUDI ARABIA
8.6.3.1. Saudi Arabia Next-generation Cancer Diagnostics Market, 2018 - 2030 (USD Million)
8.6.3.2. Key Country Dynamics
8.6.3.3. Regulatory Framework
8.6.3.4. Reimbursement Scenario
8.6.3.5. Competitive Scenario
8.6.4. UAE
8.6.4.1. UAE Next-generation Cancer Diagnostics Market, 2018 - 2030 (USD Million)
8.6.4.2. Key Country Dynamics
8.6.4.3. Regulatory Framework
8.6.4.4. Reimbursement Scenario
8.6.4.5. Competitive Scenario
8.6.5. KUWAIT
8.6.5.1. Kuwait Next-generation Cancer Diagnostics Market, 2018 - 2030 (USD Million)
8.6.5.2. Key Country Dynamics
8.6.5.3. Regulatory Framework
8.6.5.4. Reimbursement Scenario
8.6.5.5. Competitive Scenario
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.2.1. New Product Launch
9.2.2. Partnerships
9.2.3. Acquisition
9.2.4. Collaboration
9.2.5. Funding
9.3. Key Company Market Share Analysis, 2022
9.4. Company Heat Map Analysis
9.5. Company Profiles
9.5.1. JANSSEN PHARMACEUTICALS, INC.
9.5.1.1. Company Overview
9.5.1.2. Financial Performance
9.5.1.3. Product Benchmarking
9.5.1.4. Strategic Initiatives
9.5.2. NOVARTIS AG
9.5.2.1. Company Overview
9.5.2.2. Financial Performance
9.5.2.3. Product Benchmarking
9.5.2.4. Strategic Initiatives
9.5.3. F. HOFFMANN-LA ROCHE LTD
9.5.3.1. Company Overview
9.5.3.2. Financial Performance
9.5.3.3. Product Benchmarking
9.5.3.4. Strategic Initiatives
9.5.4. KONINKLIJKE PHILIPS N.V.
9.5.4.1. Company Overview
9.5.4.2. Financial Performance
9.5.4.3. Product Benchmarking
9.5.4.4. Strategic Initiatives
9.5.5. ABBOTT
9.5.5.1. Company Overview
9.5.5.2. Financial Performance
9.5.5.3. Product Benchmarking
9.5.6. GE HEALTHCARE
9.5.6.1. Company Overview
9.5.6.2. Financial Performance
9.5.6.3. Product Benchmarking
9.5.6.4. Strategic Initiatives
9.5.7. THERMO FISHER SCIENTIFIC, INC.
9.5.7.1. Company Overview
9.5.7.2. Financial Performance
9.5.7.3. Product Benchmarking
9.5.7.4. Strategic Initiatives
9.5.8. AGILENT TECHNOLOGIES, INC. (DAKO)
9.5.8.1. Company Overview
9.5.8.2. Financial Performance
9.5.8.3. Product Benchmarking
9.5.8.4. Strategic Initiatives
9.5.9. ILLUMINA, INC.
9.5.9.1. Company Overview
9.5.9.2. Financial Performance
9.5.9.3. Product Benchmarking
9.5.9.4. Strategic Initiatives
9.5.10. QIAGEN
9.5.10.1. Company Overview
9.5.10.2. Financial Performance
9.5.10.3. Product Benchmarking
9.5.10.4. Strategic Initiatives
9.5.11. CEPHEID
9.5.11.1. Company Overview
9.5.11.2. Financial Performance
9.5.11.3. Product Benchmarking
9.5.11.4. Strategic Initiatives
9.5.12. OPKO HEALTH, INC.
9.5.12.1. Company Overview
9.5.12.2. Financial Performance
9.5.12.3. Product Benchmarking
9.5.12.4. Strategic Initiatives
9.5.13. HOLOGIC, INC (GEN-PROBE)
9.5.13.1. Company Overview
9.5.13.2. Financial Performance
9.5.13.3. Product Benchmarking
9.5.13.4. Strategic Initiatives
9.5.14. PERKINELMER INC.
9.5.14.1. Company Overview
9.5.14.2. Financial Performance
9.5.14.3. Product Benchmarking
9.5.14.4. Strategic Initiatives
9.5.15. SYSMEX
9.5.15.1. Company Overview
9.5.15.2. Financial Performance
9.5.15.3. Product Benchmarking
9.5.15.4. Strategic Initiatives
9.5.16. MYRIAD GENETICS, INC.
9.5.16.1. Company Overview
9.5.16.2. Financial Performance
9.5.16.3. Product Benchmarking
9.5.16.4. Strategic Initiatives
9.5.17. ALMAC GROUP
9.5.17.1. Company Overview
9.5.17.2. Financial Performance
9.5.17.3. Product Benchmarking
9.5.17.4. Strategic Initiatives
9.5.18. EXOSOME DIAGNOSTICS, INC.
9.5.18.1. Company Overview
9.5.18.2. Financial Performance
9.5.18.3. Product Benchmarking
9.5.18.4. Strategic Initiatives
9.5.19. GENOMIC HEALTH, INC.
9.5.19.1. Company Overview
9.5.19.2. Financial Performance
9.5.19.3. Product Benchmarking
9.5.19.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 North America next-generation cancer diagnostics market, by country, 2018 - 2030 (USD Million)
Table 4 North America next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 5 North America next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 6 North America next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 7 North America next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 8 U.S next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 9 U.S next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 10 U.S next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 11 U.S. next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 12 Canada next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 13 Canada next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 14 Canada next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 15 Canada next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 16 Europe next-generation cancer diagnostics market, by country, 2018 - 2030 (USD Million)
Table 17 Europe next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 18 Europe next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 19 Europe next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 20 Europe next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 21 UK next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 22 UK next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 23 UK next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 24 UK next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 25 Germany next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 26 Germany next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 27 Germany next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 28 Germany next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 29 France next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 30 France next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 31 France next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 32 France next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 33 Italy next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 34 Italy next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 35 Italy next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 36 Italy next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 37 Spain next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 38 Spain next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 39 Spain next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 40 Spain next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 41 Denmark next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 42 Denmark next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 43 Denmark next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 44 Denmark next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 45 Sweden next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 46 Sweden next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 47 Sweden next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 48 Sweden next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 49 Norway next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 50 Norway next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 51 Norway next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 52 Norway next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 53 Asia Pacific next-generation cancer diagnostics market, by country, 2018 - 2030 (USD Million)
Table 54 Asia Pacific next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 55 Asia Pacific next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 56 Asia Pacific next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 57 Asia Pacific next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 58 China next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 59 China next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 60 China next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 61 China next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 62 Japan next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 63 Japan next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 64 Japan next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 65 Japan next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 66 India next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 67 India next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 68 India next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 69 India next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 70 South Korea next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 71 South Korea next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 72 South Korea next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 73 South Korea next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 74 Australia next-generation cancer diagnostics market, by technology 2018 - 2030 (USD Million)
Table 75 Australia next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 76 Australia next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 77 Australia next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 78 Thailand next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 79 Thailand next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 80 Thailand next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 81 Thailand next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 82 Latin America next-generation cancer diagnostics market, by country, 2018 - 2030 (USD Million)
Table 83 Latin America next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 84 Latin America next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 85 Latin America next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 86 Latin America next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 87 Brazil next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 88 Brazil next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 89 Brazil next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 90 Brazil next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 91 Mexico next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 92 Mexico next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 93 Mexico next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 94 Mexico next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 95 Argentina next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 96 Argentina next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 97 Argentina next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 98 Argentina next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 99 Middle East & Africa next-generation cancer diagnostics market, by country, 2018 - 2030 (USD Million)
Table 100 Middle East & Africa next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 101 Middle East & Africa next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 102 Middle East & Africa next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 103 Middle East & Africa next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 104 South Africa next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 105 South Africa next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 106 South Africa next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 107 South Africa next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 108 Saudi Arabia next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 109 Saudi Arabia next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 110 Saudi Arabia next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 111 Saudi Arabia next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 112 UAE next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 113 UAE next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 114 UAE next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 115 UAE next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 116 Kuwait next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 117 Kuwait next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 118 Kuwait next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 119 Kuwait next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Market summary
Fig. 4 Market segmentation & scope
Fig. 5 Market size and growth prospects
Fig. 6 Global next-generation cancer diagnostics market- Key market driver analysis
Fig. 7 Global next-generation cancer diagnostics market - Key market restraint analysis
Fig. 8 Penetration & growth prospect mapping
Fig. 9 Global next-generation cancer diagnostics market - Porter’s analysis
Fig. 10 Global next-generation cancer diagnostics market - PESTEL analysis
Fig. 11 Global next-generation cancer diagnostics market technology outlook key takeaways
Fig. 12 Global next-generation cancer diagnostics market: Technology movement analysis
Fig. 13 Next-generation sequencing market estimates, 2018 - 2030 (USD Million)
Fig. 14 qPCR & multiplexing market estimates, 2018 - 2030 (USD Million)
Fig. 15 LOAC & RT-PCR market estimates, 2018 - 2030 (USD Million)
Fig. 16 Protein microarrays market estimates, 2018 - 2030 (USD Million)
Fig. 17 DNA microarrays market estimates, 2018 - 2030 (USD Million)
Fig. 18 Global next-generation cancer diagnostics market application outlook key takeaways
Fig. 19 Global next-generation cancer diagnostics market: application movement analysis
Fig. 20 Biomarker development market estimates, 2018 - 2030 (USD Million)
Fig. 21 CTC analysis market estimates, 2018 - 2030 (USD Million)
Fig. 22 Proteomic analysis market estimates, 2018 - 2030 (USD Million)
Fig. 23 Epigenetic analysis market estimates, 2018 - 2030 (USD Million)
Fig. 24 Global next-generation cancer diagnostics market cancer type outlook key takeaways
Fig. 25 Global next-generation cancer diagnostics market: Cancer type movement analysis
Fig. 26 Lung cancer market estimates, 2018 - 2030 (USD Million)
Fig. 27 Breast cancer market estimates, 2018 - 2030 (USD Million)
Fig. 28 Colorectal cancer market estimates, 2018 - 2030 (USD Million)
Fig. 29 Cervical cancer market estimates, 2018 - 2030 (USD Million)
Fig. 30 Others market estimates, 2018 - 2030 (USD Million)
Fig. 31 Global next-generation cancer diagnostics market function outlook key takeaways
Fig. 32 Global next-generation cancer diagnostics market: Function movement analysis
Fig. 33 Therapeutic monitoring market estimates, 2018 - 2030 (USD Million)
Fig. 34 Companion diagnostics market estimates, 2018 - 2030 (USD Million)
Fig. 35 Prognostics market estimates, 2018 - 2030 (USD Million)
Fig. 36 Cancer screening market estimates, 2018 - 2030 (USD Million)
Fig. 37 Risk analysis market estimates, 2018 - 2030 (USD Million)
Fig. 38 Regional marketplace: Key takeaways
Fig. 39 Global next-generation cancer diagnostics market: Regional movement analysis
Fig. 40 North America next-generation cancer diagnostics market, 2018 - 2030 (USD Million)
Fig. 41 U.S. next-generation cancer diagnostics market, 2018 - 2030 (USD Million)
Fig. 42 Canada next-generation cancer diagnostics market, 2018 - 2030 (USD Million)
Fig. 43 Europe next-generation cancer diagnostics market, 2018 - 2030 (USD Million)
Fig. 44 UK next-generation cancer diagnostics market, 2018 - 2030 (USD Million)
Fig. 45 Germany next-generation cancer diagnostics market, 2018 - 2030 (USD Million)
Fig. 46 France next-generation cancer diagnostics market, 2018 - 2030 (USD Million)
Fig. 47 Spain next-generation cancer diagnostics market, 2018 - 2030 (USD Million)
Fig. 48 Italy next-generation cancer diagnostics market, 2018 - 2030 (USD Million)
Fig. 49 Denmark next-generation cancer diagnostics market, 2018 - 2030 (USD Million)
Fig. 50 Sweden next-generation cancer diagnostics market, 2018 - 2030 (USD Million)
Fig. 51 Norway next-generation cancer diagnostics market, 2018 - 2030 (USD Million)
Fig. 52 Asia Pacific next-generation cancer diagnostics market, 2018 - 2030 (USD Million)
Fig. 53 Japan next-generation cancer diagnostics market, 2018 - 2030 (USD Million)
Fig. 54 China next-generation cancer diagnostics market, 2018 - 2030 (USD Million)
Fig. 55 India next-generation cancer diagnostics market, 2018 - 2030 (USD Million)
Fig. 56 South Korea next-generation cancer diagnostics market, 2018 - 2030 (USD Million)
Fig. 57 Australia next-generation cancer diagnostics market, 2018 - 2030 (USD Million)
Fig. 58 Thailand next-generation cancer diagnostics market, 2018 - 2030 (USD Million)
Fig. 59 Latin America next-generation cancer diagnostics market, 2018 - 2030 (USD Million)
Fig. 60 Brazil next-generation cancer diagnostics market, 2018 - 2030 (USD Million)
Fig. 61 Mexico next-generation cancer diagnostics market, 2018 - 2030 (USD Million)
Fig. 62 Argentina next-generation cancer diagnostics market, 2018 - 2030 (USD Million)
Fig. 63 MEA next-generation cancer diagnostics market, 2018 - 2030 (USD Million)
Fig. 64 South Africa next-generation cancer diagnostics market, 2018 - 2030 (USD Million)
Fig. 65 Saudi Arabia next-generation cancer diagnostics market, 2018 - 2030 (USD Million)
Fig. 66 UAE next-generation cancer diagnostics market, 2018 - 2030 (USD Million)
Fig. 67 Kuwait next-generation cancer diagnostics market, 2018 - 2030 (USD Million)
Fig. 68 Strategy framework

Companies Mentioned

  • JANSSEN PHARMACEUTICALS, INC.
  • NOVARTIS AG
  • F. HOFFMANN-LA ROCHE LTD
  • KONINKLIJKE PHILIPS N.V.
  • ABBOTT
  • GE HEALTHCARE
  • THERMO FISHER SCIENTIFIC, INC.
  • AGILENT TECHNOLOGIES, INC. (DAKO)
  • ILLUMINA, INC.
  • QIAGEN
  • CEPHEID
  • OPKO HEALTH, INC.
  • HOLOGIC, INC (GEN-PROBE)
  • PERKINELMER INC.
  • SYSMEX
  • MYRIAD GENETICS, INC.
  • ALMAC GROUP
  • EXOSOME DIAGNOSTICS, INC.
  • GENOMIC HEALTH, INC.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages236
PublishedAugust 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 14.84 Billion
Forecasted Market Value ( USD ) by 2030 $ 29.31 Billion
Compound Annual Growth Rate9.3%
Regions CoveredGlobal
No. of Companies Mentioned19

Related Topics

Related Reports

Cancer Diagnostics Market Size, Share & Trends Analysis Report by Product (Consumables, Instruments), Type (IVD, LDT), Application (Breast Cancer, Lung Cancer), End-use, Test Type, and Segment Forecasts, 2024-2030 - Product Image

Cancer Diagnostics Market Size, Share & Trends Analysis Report by Product (Consumables, Instruments), Type (IVD, LDT), Application (Breast Cancer, Lung Cancer), End-use, Test Type, and Segment Forecasts, 2024-2030

  • Report
  • 240 Pages
  • Global
From
Next-Generation Cancer Diagnostics Market by Technology, Cancer Type, Application, Function - Global Forecast 2025-2030 - Product Image

Next-Generation Cancer Diagnostics Market by Technology, Cancer Type, Application, Function - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Next-Generation Gynecological Cancer Diagnostics Market by Components, Technology, Indication, End User - Global Forecast 2025-2030 - Product Image

Next-Generation Gynecological Cancer Diagnostics Market by Components, Technology, Indication, End User - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Blood Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Assay Kits And Reagents), By Test (Blood Test, Imaging Test), By End Use (Hospitals & Clinics), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Blood Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Assay Kits And Reagents), By Test (Blood Test, Imaging Test), By End Use (Hospitals & Clinics), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 150 Pages
  • Global
From
Next Generation Cancer Diagnostics Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Next Generation Cancer Diagnostics Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.